HOME
ABOUT US
DIRECTORY
SCIENTIFIC ACTIVITY
GRANT
SUPPORTERS
SUPPORT US!
MEMBERS
- LOGIN
- SCIENTIFIC ACTIVITY PRIVATE

HOME
ABOUT US
DIRECTORY
SCIENTIFIC ACTIVITY
GRANT
SUPPORTERS
SUPPORT US!
MEMBERS
- LOGIN
- SCIENTIFIC ACTIVITY PRIVATE

SARCOSTAGE – Actualización en sarcomas

Home
scientific activity
education
SARCOSTAGE – Actualización en sarcomas

6 July, 2020
SELNET Admin (2)
education

Presentations of the Fast Course on Soft Tissue Sarcoma, held in 2019, are available in pdf below.

1.Introducción
2. Importancia del equipo multidisciplinar
3. Radiodiagnóstico: Valoración de la respuesta al tratamiento en sarcomas
4. Aspectos prácticos del diagnóstico anatomopatológico del sarcoma
5. Aproximación quirúrgica al tratamiento de los sarcomas óseos
6.Cirugía Oncoplástica en los tumores de partes blandas
7. Principios de la cirugía del retroperitoneo
8. Avances en Radioterapia en sarcomas
9. Principios del tratamiento sistémico de los sarcomas de partes blandas

Videos are available here.

Share this:

Facebook
X
LinkedIn
WhatsApp
Telegram
Pocket
Email
Print

education

« CONTINUING MEDICAL EDUCATION

XVIII GEIS International Symposium 2020. ONLINE »

About The Author

INSTITUTO DE INVESTIGACIÓN SANITARIA FUNDACIÓN JIMÉNEZ DÍAZ (IISFJD) – Spain

Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD) is a non-profit foundation constituted by Fundación Jiménez Díaz University Hospital (FJD) and Universidad Autónoma de Madrid (UAM) in 2009. It has a well-established record of commitment to research, teaching, and clinical care-related activity. These three pillars guide the work carried out in the IIS-FJD, whose goal is to foster excellence in research, scientific and technological understanding, teaching, and training in the hospital. IIS-FJD participates in several national and international network as ECRIN –The European Clinical Research Infrastructure Network for Clinical Trials and Biotherapy, EATRIS– The European Advanced Translational Research Infrastructure in Medicine and BBMRI –Biobanking and Biomolecular Resources Research Infrastructure.

Alexander Fleming Sa (IAF) – Argentina

Founded in 1994, the Institute Alexander Fleming is the first private institution in Latin America devoted to prevention, diagnosis and integral treatment of patients with cancer. The Institute is associated to the Faculty of Medicine of the University of Buenos Aires in order to fulfill high academic and scientific goals.

Fundacao Antonio Prudente (ACC) – Brazil

This is an integrated Cancer Center for diagnosis, treatment, education and research, located in Sao Paolo, Brazil. It has achieved a leading position in the generation of scientific research in the field of oncology and is recognized internationally as a reference institution in the fight against cancer.

Sarcoma Patients EuroNet Assoc./e.V. (SPAEN) – Germany

Sarcoma Patients EuroNet Association (SPAEN) is the international network of sarcoma, GIST and desmoid patient advocacy groups. It was founded in April 2009 with the aim of extending information, support and advocacy to patient organizations for the benefit of sarcoma patients across of Europe and internationally. SPAEN is a key partner of SELNET by increasing the visibility of sarcoma patients.

Grupo Español de Investigación en Sarcomas (GEIS) – Spain

The Spanish Group for Research on Sarcomas (Grupo Español de Investigación en Sarcomas, GEIS) is a non-profit medical research association dedicated to improve the outcome of Spanish sarcoma patients through research and dissemination. Since its foundation, GEIS has carried out more than 60 multicentre clinical studies in sarcomas at both national and international levels.

Instituto Nacional de Enfermedades Neoplásicas (INEN) – Perú

The National Institute of Neoplastic Diseases, better known as INEN, is a Peruvian public hospital managed by the Ministry of Health of Peru. This hospital provides health services including detection, diagnosis, treatment and rehabilitation to cancer patients.

Fundación Amor Esperanza y Vida (FUNDAEVI) – Costa Rica

Stablished in 2012, The Foundation aims to support cancer patients, based on the principles of solidarity, work, love and respect for others. FUNDAEVI reaches this goal trough the development of projects and the promotion of healthy lifestyles in the entire population of the province of Heredia (Costa Rica).

Instituto Nacional de Cancerología (INCAN) – México

The National Institute of Cancerology is a decentralized organization of third level, linked to the Ministry of Health, which provides specialized medical care to cancer patients, involved also in Basic and Clinical Research. The INC is the coordinator of 25 State Cancer Centers (CEC) in Mexico, offering a unique possibility for designing common programs and strategies for prevention, early detection and better cancer control at a national level.

Centre Leon Berard (CLB) – France

The Centre Léon Bérard (CLB) is part of the twenty French Comprehensive Cancer Centers, providing a global management of cancer patients. The Centre is an international recognized reference cancer Centre with three essential missions: Care, Research and Education in order to improve the quality and accessibility of care for cancer patients. CLB develops an excellence and multidisciplinary research and is also a reference center within the European Reference Network (ERN) EURACAN.

IRCCS Istituto Ortopedico Rizzoli (IOR) – Italy

The Rizzoli Orthopedic Institute (IOR) is the only Italian orthopedic public hospital recognized as a National Institute for Research and Health Care (IRCCS). Its high quality healthcare is the result of intense scientific research with the aim to transfer these research results into clinical practice. The Institute founded and chair the Italian Sarcoma Group (ISG) and is a reference center in sarcoma within the European Reference Network (ERN) EURACAN.

Fondazione IRCCS Istituto Nazionale dei Tumori (INT) – Italy

Founded in 1928, Fondazione Istituto Nazionale Tumori (INT) based in Milan, is the largest comprehensive cancer centre in Italy. INT aims to provide the highest quality of care and to pursue preclinical and clinical research to translate innovation into better management for cancer patients. INT coordinates the Italian Rare Cancer Network (RTR), works with the Italian Sarcoma Group, and is a reference center in sarcoma within the European Reference Network (ERN) EURACAN.

We use cookies to ensure that we provide the best user experience on our website. If you continue to use this site we will assume that you agree.